These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3262974)

  • 1. [Effect of a streptococcal allergen on the rosette-forming capacity of the T-lymphocytes in erysipelas patients].
    Tsoĭ IG; Krifuks OI
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Jun; (6):76-80. PubMed ID: 3262974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Capacity of mononuclear cells to produce a factor that promotes E-rosette formation in different clinical forms of erysipelas].
    Tsoĭ IG
    Zh Mikrobiol Epidemiol Immunobiol; 1988 May; (5):72-7. PubMed ID: 3414237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoimmune reactions in diseases of streptococcal etiology].
    Bala MA; Korabel'nikov SV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (5):83-7. PubMed ID: 8067152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of functional disorders of the dermal T-lymphocytes and macrophages in the basic clinical forms of erysipelas].
    Tsoĭ IG; Tataeva KM; Krifuks OI
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Aug; (8):101-6. PubMed ID: 3057772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibodies to group A streptococcal polysaccharides in erysipelas].
    Borodiiuk NA; Cherkasov VL; Rassokhina II
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Jan; (1):52-6. PubMed ID: 804779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [T-cell responsiveness to specific group A streptococcus antigens in patients with primary erysipelas].
    Iudina IuV; Belaia OF; Pak SG
    Klin Lab Diagn; 2007 Nov; (11):41-4. PubMed ID: 18225491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problems of erysipelas. 3. Streptococcal vaccine treatment of relapsing erysipelas.
    Korossy S; Rajka O; Böszörményi J; Gózony M
    Acta Med Acad Sci Hung; 1968; 25(1):51-61. PubMed ID: 5678738
    [No Abstract]   [Full Text] [Related]  

  • 8. Recurrent erysipelas of the face with hyperimmune reaction to group C streptococcus.
    Dequidt L; Jullie ML; Seneschal J; Werfel T; Taïeb A
    Br J Dermatol; 2018 Aug; 179(2):524-525. PubMed ID: 29526042
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of lymphocyte cooperative interaction with neutrophils by the stimulation of lymphokine production in erysipelatous inflammation].
    Tsoĭ IG
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Oct; (10):59-64. PubMed ID: 3265249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinico-immunological evaluation of antibiotic thereapy and prevention of frequent recurrences of erysipelas].
    Cherkasov VL; Iakhontova NK; Chistenkov NA
    Klin Med (Mosk); 1974 Feb; 52(2):52-7. PubMed ID: 4466916
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibodies to type antigens of group A streptococcal cell walls in erysipelas patients].
    Cherkasov VL; Chistenkov NA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Mar; 0(3):68-73. PubMed ID: 1092110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytotoxic effect of lymphocytes on autologous blood monocytes in the presence of streptococcal group A antigens in patients with primary erysipelas].
    Bazanova EA; Nechaeva NP; Lavrent'eva NN; Bukhova VP
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):61-5. PubMed ID: 3521161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Free and bound antigen of Streptococcus group A L forms and the circulating immune complex level of erysipelas patients].
    Gorina LG; Kagan GIa; Gavrilova GA; Goncharova SA; Cherkasov VL
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Sep; (9):106-9. PubMed ID: 6195846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro detection of bacterial allergy in erysipelas].
    Kriukova SA
    Lab Delo; 1980; (8):489-90. PubMed ID: 6157905
    [No Abstract]   [Full Text] [Related]  

  • 15. [E rosette forming cells and EAC rosette forming cells].
    Tachibana T; Watanabe N; Kondo T
    Nihon Rinsho; 1978; 36(5):1034-40. PubMed ID: 97421
    [No Abstract]   [Full Text] [Related]  

  • 16. [The pathogenetic and prognostic significance of the level of class-E immunoglobulins in erysipelas].
    Ambalov IuM; Kovalenko AP; Usatkin AV; Khomchenko LN
    Vrach Delo; 1991 Sep; (9):76-9. PubMed ID: 1759439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human thymus cells: a study of rosette-forming capacity with unsensitized and sensitized erythrocytes of various species.
    Han T; Diegelman P; Subramanian S; Minowada J
    Immunology; 1979 Nov; 38(3):585-90. PubMed ID: 316414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The functional characteristics of the peripheral blood granulocytes in erysipelatous inflammation].
    Krifuks OI; Tsoĭ IG; Sagimbaeva GE
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Jun; (6):67-71. PubMed ID: 2220222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of chronic recurrent erysipelas with streptococcal vaccine].
    Haustein UF; Biella U; Tausch I; Knöll H
    Hautarzt; 1989 Apr; 40(4):215-21. PubMed ID: 2659550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cellular immunity in patients with frequently recurring erysipelas].
    Frolov VM; Rychnev VE
    Klin Med (Mosk); 1986 Mar; 64(3):55-60. PubMed ID: 3487002
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.